Tamiflu

Information on Tamiflu, Technology, Production, Manufacturing Process, Marketing, Suppliers, Distributors and Patents Information
Primary Information Services 
Home .Ordering Information. Contact

Content Headlines of CD ROM


Information Profile @ a Glance 
  • TAMIFLU (TAM-ih-flew) is a medicine to treat flu (infection caused by influenza virus). It belongs to a group of medicines called neuraminidase inhibitors. These medications attack the influenza virus and prevent it from spreading.
  • Chemists say that 13 grams of star anise could produce 1.3 grams of shikimic acid, which then could be used to make 10 Tamiflu capsules, the amount required to treat one person. Thus, one ton of shikimic acid could treat 770,000 people.
  • In 1996 Roche acquired the worldwide rights to develop and market the drug from Gilead Sciences, South San Francisco.
  • Tamiflu was launched in North America (US and Canada) and Switzerland during 1999/2000. In all key European markets, it was launched by 2002/2003.
  • Over 33 million patients have been treated with Tamiflu in about 80 countries worldwide including United States, Japan, Canada, Australia, the EU, Switzerland and Latin America.
  • Tamiflu is patent protected until 2016; the patent is owned by Gilead.
  • The cost of a box of Tamiflu in Hong Kong, 350 km southeast of Gulong, has gone from about US$25 to as much as US$130.  
  • A report in the China Daily states that the price of star anise had almost doubled.
  • The cost of shikimic acid in China rose from $40 to over $400 per kilo.
  • Potential sources of shikimic acid reportedly considered  are cinchona bark (Cinchona spp., Rubiaceae, source of quinic acid, a precursor of shikimic acid), ginkgo trees (Ginkgo biloba L., Ginkgoaceae), and the needles of giant sequoias.
All About Tamiflu 
  • Tamiflu FAQs
  • Tamiflu - avian influenza
  • More on Tamiflu
  • Avian Influenza virus
  • All About Avian Flu
Technology and Production of Tamiflu
  • Medications and Prescriptions
  • Oral Suspension
  • Oseltamivir Phosphate - CAPSULES
  • ITRI - Research Center
  • Avian Flu An Overview
  • Manufacturing of Tamiflu
  • Production of Tamiflu Capsules 

Manufacturing Companies

  • Roche Ltd
  • Indian  Manufacturers of Tamiflu
  • RANBAXY - US Trade Leads
  • Roche - Sole Manufacturer
  • Vaccine Manufacturing Company 
  • Drug Manufacturers - Generic Tamiflu
Buyers, Sellers, Distributors and Price List
  • Online Sellers for Tamiflu
  • Tamiflu - Distributor
  • Tamiflu order information form
  • Distribution and Price List 
  • Price List of Tamiflu
  • Report on the Supply of Tamiflu
  • Stockpiling of Tamiflu
  • Stock pile of Antiviral Medicine - Tamiflu 
Dosage and Drug Interaction 
  • Tamiflu Side Effects
  • Antiviral Drug: Oseltamivir
  • Tamiflu Vaccine
  • Factsheet Tamiflu
  • Dosage and Administration
  • Oseltamivir Phosphate - Dosage
  • Tamiflu Mechanism of Action

More Information On Tamiflu 

  • Disease Management Protocol
  • Tamiflu Treatment
  • Communicable Disease Control 
  • Tamiflu  - Young Children
  • Tamiflu - Canada 
Guidelines for using Tamiflu 
  • How does Tamiflu Works
  • Tamiflu Consumer Info
  • Guidelines - Tamiflu 
  • World Health guidelines - Tamiflu
  • Patient Information - Roche

Patents of Tamiflu 

  • Press Release 
  • Influenza Antiviral Drugs and Patent Law Issues
  • Patented Medicine Price Review
  • Patent Protection for Tamiflu

Tamiflu News Reports

  • Tamiflu - Pandemic Flu Fact Sheet
  • Tamiflu News and Tamiflu Drug Information Influenza (Bird Flu) News
  • Tamiflu  - Do's and Don'ts
  • Management of Flu - Tamiflu Vaccine
  • Clinical Aspects of Tamiflu 
  • Tamiflu - Report
Research papers and Studies 
  • American Pharmaceutical Association - Tamiflu 
  • FDA approved  : Tamiflu
  • Studies on Tamiflu
  • Tamiflu Prescription details
  • Tamiflu Drug Information
  • Avian Flu Treatment

Market  Reports of Tamiflu Antiviral Drug

  • TAMIFLU: Sales Performance 2006
  • Roche - Media News 
  • Hetero Drugs - Tamiflu
  • Tamiflu Vaccine - US Issue Report
  • TAMIFLU - European Report
  • Annual Report - Roche Holding Ltd. 

Order the CD ROM Today 


Primary Information Services
 21 Murugappan St, SwamyNagar Ext2, 
Ullagaram, Chennai - 600091, India.
 Phone: 91 44 22421080
  Email : informer@eth.net
Mobile number: 9940043898, 9444008898  Fax : 91 44 22423753